导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.50% | 564/1050 |
| 近一周 | -0.73% | 90/1104 |
| 近一月 | -1.85% | 206/1102 |
| 近一季 | -1.69% | 316/1092 |
| 近半年 | 2.71% | 364/1070 |
| 近一年 | -5.83% | 665/1018 |
| 近两年 | 48.91% | 511/926 |
| 近三年 | 26.08% | 419/834 |
| 成立以来 | 287.69% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.79% 802/1070 |
6.38% 602/1101 |
- - |
- - |
| 2025 | 25.21% 579/1065 |
13.49% 71/1014 |
5.27% 283/1038 |
12.69% 790/1050 |
-7.00% 803/1065 |
| 2024 | 12.71% 226/1011 |
4.34% 121/960 |
-1.97% 437/983 |
11.00% 546/991 |
-0.73% 364/1011 |
| 2023 | -15.39% 537/952 |
2.30% 490/880 |
-10.00% 770/895 |
0.43% 75/915 |
-8.50% 792/952 |
| 2022 | -20.65% 350/867 |
-18.09% 432/773 |
11.04% 224/806 |
-9.91% 239/845 |
-3.17% 586/867 |
| 2021 | -15.08% 515/740 |
-5.22% 347/580 |
12.84% 290/659 |
-17.12% 637/704 |
-4.19% 575/740 |
| 2020 | 77.72% 103/554 |
-0.46% 169/419 |
31.58% 105/466 |
18.00% 79/517 |
15.00% 203/554 |
| 2019 | 63.00% 68/410 |
33.44% 198/1149 |
4.10% 73/1231 |
7.09% 160/390 |
9.57% 171/410 |
| 2018 | -32.36% 248/349 |
- - |
- - |
- - |
-16.98% 951/1080 |
| 2017 | 37.00% 18/285 |
- - |
- - |
- - |
- - |
| 2016 | 6.69% 12/205 |
- - |
- - |
- - |
- - |
| 2015 | 40.31% 37/151 |
- - |
- - |
- - |
- - |
| 2014 | 11.53% 18/24 |
- - |
- - |
- - |
- - |
| 2013 | 17.43% 8/21 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 南方新兴消费增长股票(LOF)A VS. 东吴新产业精选股票A(580008) |